KindlyMD Secures $203 Million Credit Facility with Two Prime Lending

October 3, 2025 — Leads & Copy —KindlyMD, Inc. (NASDAQ:NAKA) announced it has secured a credit facility with Two Prime Lending Limited, receiving a $203,017,500 term loan.

The financing’s primary use was the redemption of a $200 million convertible debenture, plus 1.5% interest, with YA II PN, Ltd., managed by Yorkville Advisors, at a $2.80 per share conversion price.

Tyler Evans, Chief Investment Officer of KindlyMD, stated the partnership with Two Prime aligns with their vision and treasury strategy, enhancing KindlyMD’s balance sheet.

The Notice of Redemption for the Convertible Debenture was delivered Monday, September 15, 2025, and the redemption amount, less any amounts converted on or prior to September 29, 2025, was fully repaid on September 30, 2025.

KindlyMD, formed in 2019, focuses on value-based care and personalized medical services, leveraging data analysis to reduce opioid use and improve health outcomes. In August 2025, KindlyMD merged with Nakamoto Holdings Inc., integrating Bitcoin into global capital markets.

Two Prime Lending Limited offers secured credit solutions to institutional bitcoin holders, providing over $3 billion in lending capacity with flexible, non-rehypothecated loans.

Investor Relations Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
KindlyMD@KCSA.com

KindlyMD Media Contact:
Carissa Felger / Sam Cohen
Gasthalter & Co.
(212) 257-4170
Nakamoto@gasthalter.com

Two Prime Media Contact:
Dukas Linden Public Relations
twoprime@dlpr.com

Source: KindlyMD, Inc

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.